CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 60 filers reported holding CASI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -98.9% | 513 | -98.7% | 0.00% | – |
| Q1 2021 | $95,000 | -18.8% | 39,700 | 0.0% | 0.00% | – |
| Q4 2020 | $117,000 | +91.8% | 39,700 | 0.0% | 0.00% | – |
| Q3 2020 | $61,000 | -38.4% | 39,700 | 0.0% | 0.00% | – |
| Q2 2020 | $99,000 | +22.2% | 39,700 | 0.0% | 0.00% | – |
| Q1 2020 | $81,000 | -34.1% | 39,700 | 0.0% | 0.00% | – |
| Q4 2019 | $123,000 | -7.5% | 39,700 | 0.0% | 0.00% | – |
| Q3 2019 | $133,000 | +4.7% | 39,700 | 0.0% | 0.00% | – |
| Q2 2019 | $127,000 | +11.4% | 39,700 | 0.0% | 0.00% | – |
| Q1 2019 | $114,000 | -28.8% | 39,700 | 0.0% | 0.00% | – |
| Q4 2018 | $160,000 | -13.5% | 39,700 | 0.0% | 0.00% | – |
| Q3 2018 | $185,000 | -43.4% | 39,700 | 0.0% | 0.00% | – |
| Q2 2018 | $327,000 | – | 39,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,136,000 | 25.80% |
| Consonance Capital Management LP | 10,540,715 | $25,298,000 | 2.70% |
| Wellington Shields & Co., LLC | 1,832,769 | $4,399,000 | 1.58% |
| Tri Locum Partners LP | 1,500,000 | $3,600,000 | 0.89% |
| Wellington Shields Capital Management, LLC | 2,231,765 | $5,356,000 | 0.51% |
| Ghost Tree Capital, LLC | 650,000 | $1,560,000 | 0.37% |
| 1492 Capital Management LLC | 159,486 | $382,000 | 0.11% |
| Ikarian Capital, LLC | 1,268,154 | $3,044,000 | 0.10% |
| Sio Capital Management, LLC | 203,432 | $488,000 | 0.10% |
| Aristides Capital LLC | 63,250 | $152,000 | 0.06% |